Here are 26 new cardiology ASCs that were announced or opened in 2024, as reported by Becker's: 1. Samuel Family Cardiology is planning to open a new location in Spring, Texas. 2. The University of ...

President-elect Donald Trump will take office for the second time in January, and ASC leaders are preparing amid his plans to appoint a swath of new leaders to oversee aspects of the healthcare system ...

3. In 2023, CVS Health spent $10.6 billion to acquire primary care company Oak Street Health, which has since been a "money losing asset," according to The Wall Street Journal. Now, according to the ...

The anesthesia industry faced certain obstacles and industry-changing events in 2024, from provider shortages to reimbursement challenges and emerging technology. Here are five notes for anesthesia ...

An Elevance-backed healthcare company based in Puerto Rico — MMM Holdings — has agreed to pay more than $15 million to resolve allegations that it violated kickback laws through a gift card incentive ...

Here are four takeaways from the post: 1. North Carolina will lift CON requirements for ASCs in counties with less than 125,000 people, effective Nov. 1, 2025. Exempt ASCs will still need to satisfy ...

Bethlehem, Pa.-based St. Luke's University Health Network is constructing a new medical center, The Morning Call reported Dec. 26. The facility will house urgent care, occupational medicine, ...

Ker Leader Medical, a new ASC development company, is dedicated to preserving physician autonomy and promoting ASC independence.

Becker's has reported on three physician fraud cases since Dec. 16.

Here are 15 healthcare leadership moves for ASC leaders and physicians to know in 2024: 1. The former CEO of Walgreens' VillageMD, Tim Barry, stepped down from his position. COO Jim Murray was ...

Two Arizona residents have pleaded guilty to defrauding the Arizona Health Care Cost Containment System, Arizona's Medicaid agency, through their behavioral health clinic.

Sixteen separate cardiology practices across 12 states have agreed to pay a total of more than $17.7 million to resolve allegations they overbilled Medicare for diagnostic radiopharmaceuticals.